Search Browse Earnings

Canton Strategic Holdings, Inc.

Nasdaq:CNTN

Pharmaceutical Preparations·BRIDGEWATER, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Canton Strategic Holdings, Inc. — SlamSEC

Revenue

—

Adj. EBITDA

—

Net Income

-$9.3M

FY 2024

EPS (Diluted)

-$107.02

FY 2024

Stock Price

$4.66

+5.0%

2026-03-10

52W Range

$0.95 – $9.08

P/E Ratio

-0.0x

Market Cap

$163.3M

Cash

$6.5M

FY 2023

Total Debt

—

Net Cash

$6.5M

Enterprise Value

$156.8M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Appajosyula Sireesh